Showing results (31-40 of 97) with videos related to
Sort By:
Pageof 10
Scientific Reports|September 22, 2022
Differentiating central nervous system infection from disease infiltration in hematological malignancyEmma A Lim, James K Ruffle, Roshina Gnanadurai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphomaAndrew Hodson, Siobhan Crichton, Silvia Montoto, et al.Hematological Oncology|June 29, 2023
Central nervous system lymphomas-Assessment and treatment and prevention of central nervous system relapsePaola Ghione, Katharine L Lewis, Sabela Bobillo, et al.Advances in Therapy|January 21, 2023
Expert Consensus on the Characteristics of Patients with Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi StudySridhar Chaganti, Arie Barlev, Sophie Caillard, et al.Nature Reviews. Disease Primers|June 15, 2023
Primary central nervous system lymphomaAndrés J M Ferreri, Teresa Calimeri, Kate Cwynarski, et al.Blood|December 31, 2002
Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migrationRong Dong, Kate Cwynarski, Alan Entwistle, et al.BMC Cancer|September 10, 2022
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphomaJulia Wendler, Christopher P Fox, Elke Valk, et al.Practical Neurology|January 25, 2024
Nerve biopsy in T-cell lymphoma with neurolymphomatosis: where and whenMenelaos Pipis, Zane Jaunmuktane, Teresa Marafioti, et al.AIDS (London, England)|March 3, 2015
Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapyFerras Alwan, Annie He, Silvia Montoto, et al.British Journal of Haematology|May 19, 2025
Management of relapsed or refractory large B-cell lymphoma: A British Society for Haematology GuidelineSridhar Chaganti, Christopher P Fox, Bernard D Maybury, et al.Pageof 10